Trial Profile
Efficacy and safety of sirolimus drug-eluting coronary stent [Cre8] in patients with diabetes undergoing percutaneous coronary interventions in real world: a spanish multicentre registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2017
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms Control-8 registry
- 10 Feb 2017 New trial record